Peter Gimsing (P Gimsing)

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Gene Expression

Artificial Intelligence

Top Venues

American journal of hematology

International journal of laboratory hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Louise Redder, Tobias Wirenfeldt Klausen, Annette Juul Vangsted, Henrik Gregersen, Niels F Andersen, Robert S Pedersen, Agoston Gyula Szabo, Mikael Frederiksen, Ulf C Frølund, Carsten Helleberg, Lene Kongsgaard Nielsen, Per T Pedersen, Morten Salomo, Peter Gimsing, Henrik Frederiksen, Niels Abildgaard
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry. British journal of haematology 193 (1) (2020)
Kristian Thidemann Andersen, Tobias Klausen, Niels Abildgaard, Mette Klarskov Andersen, Niels Frost Andersen, Ulf Christian Frølund, Carsten Helleberg, Eigil Kjeldsen, Per Pedersen, Sissel Helm-Petersen, Asta Svirskaite, Birgitte Preiss, Peter Gimsing, Annette Juul Vangsted
Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry. American journal of hematology 92 (10) (2017)
N E U Hermansen, R Borup, M K Andersen, A J Vangsted, N T Clausen, D L Kristensen, F C Nielsen, Peter Gimsing
Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation. International journal of laboratory hematology 38 (3) (2016)